Trial Profile
Current status of functional dyspepsia treatment in Kurashiki district -multicener collaborative research-
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Acotiamide (Primary) ; VECAM
- Indications Dyspepsia
- Focus Therapeutic Use
- Acronyms Kurashiki FD study
- 10 Sep 2018 Status changed from recruiting to discontinued.
- 09 Apr 2018 Status changed from not yet recruiting to recruiting.
- 02 Dec 2016 New trial record